Skip to main content
. 2015 Nov 28;4(12):701–710. doi: 10.1002/psp4.12047

Figure 3.

Figure 3

Effects of silibinin (480 mg three times daily for 4 days) on (a,c,e) Cmax and (b,d,f) AUC0‐inf of (a,b) raloxifene, (c,d) raloxifene‐4′‐glucuronide, and (e,f) raloxifene‐6‐glucuronide in 16 healthy volunteers following oral administration of raloxifene (60 mg). Open symbols connected by solid lines (black) denote individual values. Solid symbols connected by dashed lines (crimson) denote geometric means.